William Creasman to Breast Neoplasms
This is a "connection" page, showing publications William Creasman has written about Breast Neoplasms.
Connection Strength
1.121
-
What is the significance of gynecologic symptoms in the participants in the NSABP study? Am J Obstet Gynecol. 2011 Dec; 205(6):511-2.
Score: 0.197
-
Hormone replacement and breast cancer risk: reconsidering the data. Oncology (Williston Park). 2009 Nov 15; 23(12):1099-100; author reply 1100, 1102.
Score: 0.174
-
Hormone replacement therapy after cancers. Curr Opin Oncol. 2005 Sep; 17(5):493-9.
Score: 0.130
-
Breast cancer: the role of hormone therapy. Semin Reprod Med. 2005 May; 23(2):167-71.
Score: 0.127
-
Estrogen and cancer. Gynecol Oncol. 2002 Jul; 86(1):1-9.
Score: 0.104
-
An experience with estrogen replacement therapy in breast cancer survivors. Int J Fertil Womens Med. 1999 Jun-Aug; 44(4):186-92.
Score: 0.084
-
HRT and women who have had breast or endometrial cancer. J Epidemiol Biostat. 1999; 4(3):217-20; discussion 221-5.
Score: 0.082
-
Is there an association between hormone replacement therapy and breast cancer? J Womens Health. 1998 Dec; 7(10):1231-46.
Score: 0.081
-
Replacement therapy for breast cancer survivors. A pilot study. Cancer. 1995 Nov 15; 76(10 Suppl):2075-8.
Score: 0.066
-
Estrogen replacement therapy: is previously treated cancer a contraindication? Obstet Gynecol. 1991 Feb; 77(2):308-12.
Score: 0.047
-
WHI: Now that the dust has settled: a commentary. Am J Obstet Gynecol. 2003 Sep; 189(3):621-6.
Score: 0.028
-
Effects of long-term estrogen replacement therapy. II. Neoplasia. Am J Obstet Gynecol. 1979 Mar 01; 133(5):537-47.
Score: 0.001